MSLE
Satellos Bioscience Inc.
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 6-K | 8/14/2026 | View on SEC |
| SUPPL | 8/14/2026 | View on SEC |
| 6-K | 8/13/2026 | View on SEC |
| F-X | 8/11/2026 | View on SEC |
| F-10 | 8/11/2026 | View on SEC |
| 6-K | 7/8/2026 | View on SEC |
| 6-K | 6/29/2026 | View on SEC |
| 6-K | 6/25/2026 | View on SEC |
| 6-K | 6/18/2026 | View on SEC |
| 6-K | 6/17/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | MSLE |
| Company Name | Satellos Bioscience Inc. |
| CIK | 1421642 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | other |
| Fiscal Year End | 1231 |
| State of Incorporation | Z4 |
| Phone | 647-660-1780 |